Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)

Abstract

The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogenic and antithrombotic effects, also an emphasis has been made on the safety of the drug.

Authors and Affiliations

V. V. Poltorak, N. A. Kravchun, M. Yu. Gorshunskaya, N. S. Krasova

Keywords

Related Articles

Cardiovascular Status and Blood Lipids in Childhood-Onset Growth Hormone Deficiency in Young Adults (Literature Review and Own Observations)

The analysis of scientific literature on the features of clinical course of childhood-onset growth hormone deficiency (GHD) in young adults has been carried out. The focus was on the state of lipid metabolism, as well as...

Typical mistakes in the diagnosis and treatment of diabetes mellitus

The lecture describes in detail the typical mistakes and difficulties of therapy with methodologies of their correction that are made both from the side of physicians and diabetes mellitus patients. The recommendations a...

Some aspects concerning abdominal obesity diagnosis in city population of Ukraine

Background. Optimized preventive approaches concerning the development of comorbidity in the patients with overweight of various degree is a topical issue of medical science. Efficiency of such approaches depends on a wh...

Assessment of Glycemia Impact on the Parameters of Sleep in Type 1 Diabetes Mellitus: the Results of Cross-Sectional Cohort Trial

This study demonstrates the impact of glycemia according to daily monitoring of blood glucose on parameters of nocturnal sleep in type 1 diabetic patients, regardless of the glycated haemoglobin level.

Effect of Infusion Therapy on the Level of Ketone Bodies in the Blood of Patients with Diabetes Mellitus Complicated by Ketoacidosis

The objective of the study was to investigate the effect of infusion therapy with multicomponent solution (Xylat) on the level of ketone bodies in the blood of patients with diabetes mellitus complicated by ketoacidosis....

Download PDF file
  • EP ID EP226795
  • DOI -
  • Views 48
  • Downloads 0

How To Cite

V. V. Poltorak, N. A. Kravchun, M. Yu. Gorshunskaya, N. S. Krasova (2014). Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation). Міжнародний ендокринологічний журнал, 1(57), 77-89. https://europub.co.uk./articles/-A-226795